Tech Company Financing Transactions
iRhythm Technologies Funding Round
On 10/26/2011, iRhythm Technologies landed $7 million in Series C funding from Kaiser Permanente Ventures.
Transaction Overview
Company Name
Announced On
10/26/2011
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series C
Investors
Proceeds Purpose
This funding will enable iRhythm to rapidly expand our commercial efforts, given the high demand for the Zio Patch.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
650 Townsend St. 500
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Website
Email Address
Overview
iRhythm's goal is to reduce healthcare costs and improve arrhythmia detection, characterization and diagnosis by providing simple, seamless integration of heart rhythm data from client to cloud to clinician. Offering services like the ZIO Service to analyze heart beats has lead to the largest cardiac rhythm database in the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin King
Chief Financial Officer
Matthew Garrett
Executive Vice President
Mark Topash
VP - Customer Service
Allan Wilsker
VP - Human Resources
Kaja Odegard
VP - Operations
Judy Lenane
VP - R & D
Mark Day
VP - Sales
David Vort
Browse more venture capital transactions:
Prev: 10/26/2011: ZeaChem venture capital transaction
Next: 10/26/2011: CrowdOptic venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs